HSS is committed to generating evidence that informs clinical practice, policy decisions, and public health interventions for liver diseases in Somalia and the broader East African region.
Ongoing Research Studies
Somalia National Hepatitis B & C Prevalence Study
National seroprevalence survey across all regions to establish baseline data for hepatitis elimination strategy.
Active
2024-2026
Lead Investigator: HSS Research Committee
Partners: Ministry of Health, WHO Somalia, UNICEF
Hepatocellular Carcinoma Registry Initiative
Establishing Somalia’s first liver cancer registry and biorepository for epidemiological research.
Active
2025-2027
Lead Investigator: Dr. Mohamed A. Hassan-Kadle
Partners: Major Hospitals Network, African Liver Cancer Consortium
MAFLD Prevalence in Urban Somalia
Investigating metabolic-associated fatty liver disease prevalence in Mogadishu and Hargeisa urban populations.
Planning
2025-2026
Lead Investigator: HSS Metabolic Liver Disease Working Group
Partners: Somali Medical Universities
Traditional Medicine & Liver Toxicity Study
Assessing hepatotoxic effects of commonly used traditional medicines and herbal remedies in Somalia.
Active
2024-2025
Lead Investigator: HSS Toxicology & Public Health Committee
Partners: Regional Poison Control Centers
Somali Hepatitis Registry
A national surveillance system tracking hepatitis B and C infections, treatment outcomes, and disease progression. The registry supports evidence-based policy making and monitors progress toward WHO elimination targets.